François Martelet

Chief Tech/Sci/R&D Officer at SCANDION ONCOLOGY A/S

66 year

Health Technology

Consumer Services

Finance

Profile

Dr. François R.
Martelet is a Chief Medical Officer at Scandion Oncology A/S, an Independent Director at Novigenix SA and a Senior Advisor at Ennovance Capital LLC.
He is on the Board of Directors at Novigenix SA. Dr. Martelet was previously employed as a Chief Executive Officer by Vivesto AB, a Chief Executive Officer & Executive Director by NetScientific Plc, a Chief Executive Officer by Topotarget A/S, a President & Chief Executive Officer by AVAX Technologies, Inc., a Vice President & Global Franchise Head-Oncology by Merck & Co., Inc., a Head-Regional Pharma by Novartis AG, a Chairman by Glycotest, Inc., a Chairman by ProAxsis Ltd., a Senior Vice President-International Operations by Stallergenes SAS, and a Chairman by Vortex BioSciences, Inc. He received his graduate degree from Burgundy School of Business, an MBA from the University of Dijon and a doctorate degree from the University of Dijon.

François Martelet active positions

Companies	Position	Start
SCANDION ONCOLOGY A/S	Chief Tech/Sci/R&D Officer	-
Ennovance Capital LLC Ennovance Capital LLC Investment ManagersFinance Ennovance Capital invests in middle market companies located in the United States. The firm focuses on companies operating in the fields of chemicals, allied products, healthcare and related specialty material sectors. It provides financing for growth stage capital requirements with investment size of USD 200 million and above.	Corporate Officer/Principal	2010-01-26
Novigenix SA Novigenix SA Medical SpecialtiesHealth Technology Develops molecular diagnostics for cancer	Director/Board Member	2019-06-17

All active positions of François Martelet

Former positions of François Martelet

Companies	Position	End
VIVESTO AB	Chief Executive Officer	2022-07-20
EMV CAPITAL PLC	Chief Executive Officer	2019-04-29
TOPOTARGET A/S	Chief Executive Officer	2012-08-29
AVAX TECHNOLOGIES, INC.	Chief Executive Officer	2008-12-31
MERCK & CO., INC.	Corporate Officer/Principal	2006-11-30

See the detail of François Martelet's experience

Training of François Martelet

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of François Martelet's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	16
Merck & Co., Inc. Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines	Health Technology
AVAX Technologies, Inc. AVAX Technologies, Inc. BiotechnologyHealth Technology Operates as development stage company with interest in the development and future commercialization of individualized cancer vaccines	Health Technology
Novartis AG Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products	Health Technology
Stallergenes SA Stallergenes SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products used for the treatment of allergy-related respiratory diseases	Health Technology
Topotarget A/S Topotarget A/S Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceuticals	Health Technology
Vivesto AB Vivesto AB Pharmaceuticals: GenericHealth Technology Develops cancer drugs based on nanotechnology for human and veterinary use	Health Technology
University of Dijon University of Dijon Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
EMV Capital Plc EMV Capital Plc Medical SpecialtiesHealth Technology Identifies, develops and commercializes transformative biomedical & healthcare technologies	Health Technology
Ennovance Capital LLC Ennovance Capital LLC Investment ManagersFinance Ennovance Capital invests in middle market companies located in the United States. The firm focuses on companies operating in the fields of chemicals, allied products, healthcare and related specialty material sectors. It provides financing for growth stage capital requirements with investment size of USD 200 million and above.	Finance
Université de Paris 5 René Descartes Université de Paris 5 René Descartes Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Burgundy School of Business Burgundy School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Novigenix SA Novigenix SA Medical SpecialtiesHealth Technology Develops molecular diagnostics for cancer	Health Technology
Vortex BioSciences, Inc. Vortex BioSciences, Inc. Medical SpecialtiesHealth Technology Develops a novel liquid biopsy automated instrument and micro fluidic cartridge for the isolation of circulating tumor cells	Health Technology
Glycotest, Inc. Glycotest, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops unique and non-invasive blood tests for liver cancers and fibrosis-cirrhosis	Electronic Technology
ProAxsis Ltd. ProAxsis Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products through online store	Health Technology
Scandion Oncology A/S Scandion Oncology A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for chemotherapy resistance mechanisms	Health Technology